Neogap Therapeutics
Sweden · Biotechnology, Health Care, Therapeutics
Neogap Therapeutics is a Swedish clinical-stage biotechnology company focused on developing personalized cancer cell therapy, particularly the pTTL (personalised Tumour Trained Lymphocytes) to treat solid tumors through immune system training.
Key facts
- Headquarters
- Sweden
- Employees
- 26
- Industries
- Biotechnology, Health Care, Therapeutics
- Status
- Private
- Website
- neogap.se
- Company page
Recent activity at Neogap Therapeutics
Neogap Therapeutics in the news
Companies similar to Neogap Therapeutics
- GenSight Biologics · Biotechnology, Health Care, Therapeutics
- Valink Therapeutics · Biotechnology, Health Care, Therapeutics
- Nuvig Therapeutics · Biotechnology, Health Care, Therapeutics
- Mosaic Therapeutics · Biotechnology, Health Care, Therapeutics
- Paradigm Biopharmaceuticals · Biotechnology, Health Care, Therapeutics
About Neogap Therapeutics: questions and answers
What does Neogap Therapeutics do?
Neogap Therapeutics is a Swedish clinical-stage biotechnology company focused on developing personalized cancer cell therapy, particularly the pTTL (personalised Tumour Trained Lymphocytes) to treat solid tumors through immune system training.
Where is Neogap Therapeutics headquartered?
Neogap Therapeutics is headquartered in Sweden.
How many employees does Neogap Therapeutics have?
Neogap Therapeutics has about 26 employees.
What is the latest news on Neogap Therapeutics?
On Nov 04, 2024, Neogap Therapeutics partners with NorthX Biologics to advance scalable manufacturing for its novel cancer cell therapy
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy